Volume 150, Issue 3, Pages 734-757.e1 (March 2016) The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy  Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude, William Paterson Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude, William Paterson  Gastroenterology  Volume 150, Issue 3, Pages 734-757.e1 (March 2016) DOI: 10.1053/j.gastro.2015.12.003 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 Algorithm for preconception counseling in women with IBD. HBI, Harvey–Bradshaw Index; SCCAI, Simple Clinical Colitis Activity Index; CDAI, Crohn’s Disease Activity Index; CRP, C-reactive protein; MTX, methotrexate DBP, dibutyl phthalate. Gastroenterology 2016 150, 734-757.e1DOI: (10.1053/j.gastro.2015.12.003) Copyright © 2016 AGA Institute Terms and Conditions

Figure 2 Algorithm for induction therapy in pregnant women with IBD. ∗Individualized per existing clinical practice guidelines and, in the case of UC, according to disease severity. †Generally, if GA is less than 37 weeks, the theoretical risk of induction therapy would be less than the risk of preterm delivery. GA, gestational age. Gastroenterology 2016 150, 734-757.e1DOI: (10.1053/j.gastro.2015.12.003) Copyright © 2016 AGA Institute Terms and Conditions